120 related articles for article (PubMed ID: 37179010)
1. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
Ke D; Yu Y; Li C; Han J; Xu J
Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
[TBL] [Abstract][Full Text] [Related]
3. JNK1 regulates RANKL-induced osteoclastogenesis
Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
[TBL] [Abstract][Full Text] [Related]
4. 1α,25-(OH)
Yu C; Zhu Y; Lv X; Wang Y
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):878-885. PubMed ID: 34780049
[TBL] [Abstract][Full Text] [Related]
5. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
Chen XX; Wu HJ; Ke DS; Zhu YR
In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
[TBL] [Abstract][Full Text] [Related]
6. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
[TBL] [Abstract][Full Text] [Related]
7. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
Zhang G; Wang Y; Tang G; Ma Y
BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
[TBL] [Abstract][Full Text] [Related]
8. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen.
Cheng L; Zhu Y; Ke D; Xie D
Cell Prolif; 2020 Apr; 53(4):e12789. PubMed ID: 32157750
[TBL] [Abstract][Full Text] [Related]
10. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.
Li P; Schwarz EM; O'Keefe RJ; Ma L; Boyce BF; Xing L
J Bone Miner Res; 2004 Feb; 19(2):207-13. PubMed ID: 14969390
[TBL] [Abstract][Full Text] [Related]
11. ECSIT is essential for RANKL-induced stimulation of mitochondria in osteoclasts and a target for the anti-osteoclastogenic effects of estrogens.
Marques-Carvalho A; Sardão VA; Kim HN; Almeida M
Front Endocrinol (Lausanne); 2023; 14():1110369. PubMed ID: 37152948
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-activated autophagy plays a negative role in its anti-osteoclastogenic effect.
Ke D; Wang Y; Yu Y; Wang Y; Zheng W; Fu X; Han J; Zhang G; Xu J
Mol Cell Endocrinol; 2020 Jan; 500():110637. PubMed ID: 31678610
[TBL] [Abstract][Full Text] [Related]
13. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
Zhong J; Wang Z; Yuan W; Shen Y; Chen L
Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
[TBL] [Abstract][Full Text] [Related]
15. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits the migration of osteoclast precursors and osteoclastogenesis by repressing CCL3 production.
Liang Z; Xue Y; Wang T; Xie Q; Lin J; Wang Y
BMC Complement Med Ther; 2020 Jul; 20(1):234. PubMed ID: 32703287
[TBL] [Abstract][Full Text] [Related]
17. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
19. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
Bharti AC; Takada Y; Aggarwal BB
J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
[TBL] [Abstract][Full Text] [Related]
20. The Fractalkine-CX3CR1 Axis Regulates Non-inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival.
Kuboi Y; Kuroda Y; Ohkuro M; Motoi S; Tomimori Y; Yasuda H; Yasuda N; Imai T; Matsuo K
JBMR Plus; 2022 Oct; 6(10):e10680. PubMed ID: 36248274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
